+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Active Pharmaceutical Ingredient Market Share, Size, Trends, Industry Analysis Report, By Product Type; By Form; By Manufacturer Type; By Application; By Regions; Segment Forecast, 2020 - 2027

  • ID: 5261937
  • Report
  • August 2020
  • Region: Global
  • 122 Pages
  • Polaris Market Research

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca
  • Boehringer Ingelheim
  • Cipla Inc.
  • ELI Lilly
  • GlaxoSmithKline PLC
The global active pharmaceutical ingredient (API) market size is expected to reach USD 306.1 billion by 2027 according to this new study. The report “Active pharmaceutical Ingredient (API) market Share, Size, Trends, Industry Analysis Report, By Product Type (Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application (Cardiology, Oncology, CNS & Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Others), By Regions; Segment Forecast, 2020 -2027”gives a detailed insight into current market dynamics and provides analysis on future market growth.







Active Pharmaceutical Ingredient (API) is a substance involved in the finished pharmaceutical product (FPP), aimed to enhance the pharmacological activity or have direct impact in the cure, mitigation, diagnosis, treatment of disease or in modifying, correcting or restoring physiological functions in the human body. Drug products are composed of various components, API is the primary ingredient of a drug product, for instance, capsule or a tablet. APIs form used in the formulation is the most stable crystalline form, thermo-dynamically.

The prominent factors favoring the global market include the sudden outbreak of novel corona virus, which is rapidly escalating the demand for pharmaceuticals and thereby fueling the overall market growth. Additionally, rise in aging population, rising cases of cardiovascular diseases, cancer, AIDs, other infectious diseases, are further contributing to augmenting demand for APIs that are used in drugs. For instance, according to a report published in March 2020, by World Health Organization (WHO), the number of COVID-19 patients increased to 200,000 and in almost after twelve-day period, the number would exceed by 100,000. Moreover, rising incidence of cardiovascular, oncology, diabetes and lifestyle diseases coupled with rising geriatric populace is furthermore surging the overall demand for the global market.

Market participants such as AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy’s Laboratories Ltd., ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd. are some of the key players operating in the global market.

Players in the market are focusing on developing active pharmaceutical Ingredient to suffice the rising demand of critical drugs for the treatment of numerous diseases. For the treatment of various diseases such as cancer, HIV, arthritis, Hepatitis-B, diabetes, cardiovascular diseases, Aids and various others, which are responsible for the majority of deaths across the globe, the innovation and demand for pharmaceuticals has witnessed elevated graph over the few decades. This has further resulted in rise in growth of API during the past years and also over the forecast period.

Major players in the market are strengthening their capabilities to enhance their product portfolio and further establish their market place. For instance, on July, 2020, Advert International signed an agreement for the acquisition of RA Chem Pharma Ltd, an integrated pharmaceutical company by Micro Labs Ltd. for USD 1.7 billion. Advert International aims for building one of the major API platforms and is expected to leverage their operational and financial resources across the globe to scale RA Chem Pharma.

The publisher has segmented the Active Pharmaceutical Ingredient market on the basis of product type, form, manufacturer type, application and region

Active Pharmaceutical Ingredient Product Type Outlook (Revenue-USD Million, 2016-2027)


Monoclonal Antibodies
Immunoglobulin
Cytokines
Insulin
Peptide Hormones
Blood Factors
Peptide Antibiotics
Vaccines
Small Molecule Antibiotics

Highly Potent Active Pharmaceutical Ingredient (HPAPI)
Others

Active Pharmaceutical Ingredient Form Outlook (Revenue-USD Million, 2016-2027)


Aqueous
Non-Aqueous Liquid
Dry Powder

Active Pharmaceutical Ingredient Manufacturer Type Outlook (Revenue-USD Million, 2016-2027)


Captive
Merchant

Active Pharmaceutical Ingredient Application Outlook (Revenue-USD Million, 2016-2027)


Cardiology
Oncology
CNS & Neurology
Orthopedic
Endocrinology
Pulmonology
Gastroenterology
Nephrology
Ophthalmology
Others

Active Pharmaceutical Ingredient Regional Outlook (Revenue-USD Million, 2016-2027)


North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Central & South America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Frequently Asked Questions about the Active Pharmaceutical Ingredient Market

What is the estimated value of the Active Pharmaceutical Ingredient Market?

The Active Pharmaceutical Ingredient Market was estimated to be valued at $177.4 Billion in 2020.

What is the growth rate of the Active Pharmaceutical Ingredient Market?

The growth rate of the Active Pharmaceutical Ingredient Market is 7.1%, with an estimated value of $306.1 Billion by 2027.

What is the forecasted size of the Active Pharmaceutical Ingredient Market?

The Active Pharmaceutical Ingredient Market is estimated to be worth $306.1 Billion by 2027.

Who are the key companies in the Active Pharmaceutical Ingredient Market?

Key companies in the Active Pharmaceutical Ingredient Market include AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Boehringer Ingelheim, Bristol, Myers Squibb, Cipla Inc. and ELI Lilly.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca
  • Boehringer Ingelheim
  • Cipla Inc.
  • ELI Lilly
  • GlaxoSmithKline PLC
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Active Pharmaceutical Ingredient Market Insights
4.1. Active Pharmaceutical Ingredient - Industry snapshot
4.2. Active Pharmaceutical Ingredient Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Surge in the infectious diseases
4.2.1.2. Growing Importance of Generics
4.2.2. Restraints and Challenges
4.2.2.1. Side effects associated of drugs
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Active Pharmaceutical Ingredient Market Industry trends

5. Active Pharmaceutical Ingredient Market Assessment by Product Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Active Pharmaceutical Ingredient Market, By Product Type, 2015 - 2026 (USD Million)
5.3. Monoclonal Antibodies
5.3.1. Global Active Pharmaceutical Ingredient Market, by Monoclonal Antibodies, by Region, 2016 -2027 (USD Million)
5.4. Immunoglobulin
5.4.1. Global Active Pharmaceutical Ingredient Market, by Immunoglobulin, by Region, 2016 -2027 (USD Million)
5.5. Cytokines
5.5.1. Global Active Pharmaceutical Ingredient Market, by Cytokines, by Region, 2016 -2027 (USD Million)
5.6. Insulin
5.6.1. Global Active Pharmaceutical Ingredient Market, by Insulin, by Region, 2016 -2027 (USD Million)
5.7. Peptide Hormones
5.7.1. Global Active Pharmaceutical Ingredient Market, by Peptide Hormones, by Region, 2016 -2027 (USD Million)
5.8. Blood Factors
5.8.1. Global Active Pharmaceutical Ingredient Market, by Blood Factors, by Region, 2016 -2027 (USD Million)
5.9. Peptide Antibiotics
5.9.1. Global Active Pharmaceutical Ingredient Market, by Peptide Antibiotics, by Region, 2016 -2027 (USD Million)
5.10. Vaccines
5.10.1. Global Active Pharmaceutical Ingredient Market, by Vaccines, by Region, 2016 -2027 (USD Million)
5.11. Small Molecule Antibiotics
5.11.1. Global Active Pharmaceutical Ingredient Market, by Small Molecule Antibiotics, by Region, 2016 -2027 (USD Million)
5.12. Highly Potent Active Pharmaceutical Ingredient (HPAPI)
5.12.1. Global Active Pharmaceutical Ingredient Market, by Highly Potent Active Pharmaceutical Ingredient (HPAPI), by Region, 2016 -2027 (USD Million)
5.13. Others
5.13.1. Global Active Pharmaceutical Ingredient Market, by Others, by Region, 2016 -2027 (USD Million)

6. Global Active Pharmaceutical Ingredient Market, by Form
6.1. Key Findings
6.2. Introduction
6.2.1. Global Active Pharmaceutical Ingredient Market, By Form, 2015 - 2026 (USD Million)
6.3. Aqueous
6.3.1. Global Active Pharmaceutical Ingredient Market, by Aqueous, By Region, 2016 -2027 (USD Million)
6.4. Non-Aqueous Liquid
6.4.1. Global Active Pharmaceutical Ingredient Market, by Non-Aqueous Liquid, by Region, 2016 -2027 (USD Million)
6.5. Dry Powder
6.5.1. Global Active Pharmaceutical Ingredient Market, by Dry Powder, by Region, 2016 -2027 (USD Million)

7. Global Active Pharmaceutical Ingredient Market, by Manufacturer
7.1. Key Findings
7.2. Introduction
7.2.1. Global Active Pharmaceutical Ingredient Market, By Manufacturer, 2015 - 2026 (USD Million)
7.3. Captive
7.3.1. Global Active Pharmaceutical Ingredient Market, by Captive, By Region, 2016 -2027 (USD Million)
7.4. Merchant
7.4.1. Global Active Pharmaceutical Ingredient Market, by Merchant, by Region, 2016 -2027 (USD Million)

8. Active Pharmaceutical Ingredient Market Assessment by Application
8.1. Key Findings
8.2. Introduction
8.2.1. Global Active Pharmaceutical Ingredient Market, By Application, 2015 - 2026 (USD Million)
8.3. Cardiology
8.3.1. Global Active Pharmaceutical Ingredient Market, by Cardiology, by Region, 2016 -2027 (USD Million)
8.4. Oncology
8.4.1. Global Active Pharmaceutical Ingredient Market, by Oncology, by Region, 2016 -2027 (USD Million)
8.5. CNS & Neurology
8.5.1. Global Active Pharmaceutical Ingredient Market, by CNS & Neurology, by Region, 2016 -2027 (USD Million)
8.6. Orthopedic
8.6.1. Global Active Pharmaceutical Ingredient Market, by Orthopedic, by Region, 2016 -2027 (USD Million)
8.7. Endocrinology
8.7.1. Global Active Pharmaceutical Ingredient Market, by Endocrinology, by Region, 2016 -2027 (USD Million)
8.8. Pulmonology
8.8.1. Global Active Pharmaceutical Ingredient Market, by Pulmonology, by Region, 2016 -2027 (USD Million)
8.9. Gastroenterology
8.9.1. Global Active Pharmaceutical Ingredient Market, by Gastroenterology, by Region, 2016 -2027 (USD Million)
8.10. Nephrology
8.10.1. Global Active Pharmaceutical Ingredient Market, by Nephrology, by Region, 2016 -2027 (USD Million)
8.11. Ophthalmology
8.11.1. Global Active Pharmaceutical Ingredient Market, by Ophthalmology, by Region, 2016 -2027 (USD Million)
8.12. Others
8.12.1. Global Active Pharmaceutical Ingredient Market, by Other Applications, by Region, 2016 -2027 (USD Million)

9. Active Pharmaceutical Ingredient Market Assessment by Geography
9.1. Key findings
9.2. Introduction
9.2.1. Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016 -2027 (USD Million)
9.3. Active Pharmaceutical Ingredient Market - North America
9.3.1. North America: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.3.2. North America: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.3.3. North America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
9.3.4. North America: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.3.5. Active Pharmaceutical Ingredient Market - U. S.
9.3.5.1. U. S.: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.3.5.2. U. S.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.3.5.3. U. S.: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.3.5.4. U. S.: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.3.6. Active Pharmaceutical Ingredient Market - Canada
9.3.6.1. Canada: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.3.6.2. Canada.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.3.6.3. Canada: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.3.6.4. Canada: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.4. Active Pharmaceutical Ingredient Market - Europe
9.4.1. Europe: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.4.2. Europe.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.4.3. Europe: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.4.4. Europe: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.4.5. Active Pharmaceutical Ingredient Market - UK
9.4.5.1. UK: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.4.5.2. UK.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.4.5.3. UK: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.4.5.4. UK: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.4.6. Active Pharmaceutical Ingredient Market - France
9.4.6.1. France: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.4.6.2. France.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.4.6.3. France: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.4.6.4. France: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.4.7. Active Pharmaceutical Ingredient Market - Germany
9.4.7.1. Germany: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.4.7.2. Germany.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.4.7.3. Germany: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.4.7.4. Germany: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.4.8. Active Pharmaceutical Ingredient Market - Italy
9.4.8.1. Italy: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.4.8.2. Italy.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.4.8.3. Italy: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.4.8.4. Italy: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.4.9. Active Pharmaceutical Ingredient Market - Spain
9.4.9.1. Spain: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.4.9.2. Spain.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.4.9.3. Spain: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.4.9.4. Spain: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.4.10. Active Pharmaceutical Ingredient Market - Netherlands
9.4.10.1. Netherlands: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.4.10.2. Netherlands.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.4.10.3. Netherlands: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.4.10.4. Netherlands: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.4.11. Active Pharmaceutical Ingredient Market - Austria
9.4.11.1. Austria: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.4.11.2. Austria.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.4.11.3. Austria: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.4.11.4. Austria: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.5. Active Pharmaceutical Ingredient Market - Asia-Pacific
9.5.1. Asia Pacific: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.5.2. Asia Pacific.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.5.3. Asia-pacific: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.5.4. Asia-pacific: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.5.5. Active Pharmaceutical Ingredient Market - China
9.5.5.1. China: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.5.5.2. China.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.5.5.3. China: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.5.5.4. China: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.5.6. Active Pharmaceutical Ingredient Market - India
9.5.6.1. India: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.5.6.2. India.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.5.6.3. India: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.5.6.4. India: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.5.7. Active Pharmaceutical Ingredient Market - Malaysia
9.5.7.1. Malaysia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.5.7.2. Malaysia.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.5.7.3. Malaysia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.5.7.4. Malaysia: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.5.8. Active Pharmaceutical Ingredient Market - Japan
9.5.8.1. Japan: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.5.8.2. Japan.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.5.8.3. Japan: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.5.8.4. Japan: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.5.9. Active Pharmaceutical Ingredient Market - Indonesia
9.5.9.1. Indonesia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.5.9.2. Indonesia.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.5.9.3. Indonesia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.5.9.4. Indonesia: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.5.10. Active Pharmaceutical Ingredient Market - South Korea
9.5.10.1. South Korea: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.5.10.2. South Korea.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.5.10.3. South Korea: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.5.10.4. South Korea: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.6. Active Pharmaceutical Ingredient Market - Middle East & Africa
9.6.1. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.6.2. Middle East & Africa.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.6.3. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.6.4. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.6.5. Active Pharmaceutical Ingredient Market - Saudi Arabia
9.6.5.1. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.6.5.2. Saudi Arabia.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.6.5.3. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.6.5.4. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.6.6. Active Pharmaceutical Ingredient Market - UAE
9.6.6.1. UAE: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.6.6.2. UAE.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.6.6.3. UAE: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.6.6.4. UAE: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.6.7. Active Pharmaceutical Ingredient Market - Israel
9.6.7.1. Israel: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.6.7.2. Israel.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.6.7.3. Israel: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.6.7.4. Israel: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.6.8. Active Pharmaceutical Ingredient Market - South Africa
9.6.8.1. South Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.6.8.2. South Africa.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.6.8.3. South Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.6.8.4. South Africa: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.7. Active Pharmaceutical Ingredient Market - Latin America
9.7.1. Latin America: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.7.2. Latin America.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.7.3. Latin America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.7.4. Latin America: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.7.5. Active Pharmaceutical Ingredient Market - Mexico
9.7.5.1. Mexico: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.7.5.2. Mexico.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.7.5.3. Mexico: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.7.5.4. Mexico: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.7.6. Active Pharmaceutical Ingredient Market - Brazil
9.7.6.1. Brazil: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.7.6.2. Brazil.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.7.6.3. Brazil: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.7.6.4. Brazil: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)
9.7.7. Active Pharmaceutical Ingredient Market - Argentina
9.7.7.1. Argentina: Active Pharmaceutical Ingredient Market, By Product Type, 2016 -2027 (USD Million)
9.7.7.2. Argentina.: Active Pharmaceutical Ingredient Market, By Form, 2016 -2027 (USD Million)
9.7.7.3. Argentina: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 -2027 (USD Million)
9.7.7.4. Argentina: Active Pharmaceutical Ingredient Market, By Application, 2016 -2027 (USD Million)

10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion & Acquisition
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles
11.1. AbbVie Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Albemarle Corporation
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. AstraZeneca
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Aurobindo Pharma
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Boehringer Ingelheim
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Bristol-Myers Squibb
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Cipla Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. Dr. Reddy's Laboratories Ltd.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. ELI Lilly and Company
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. F. Hoffmann-La Roche AG
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. GlaxoSmithKline PLC
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development
11.12. Lonza Group
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Benchmarking
11.12.4. Recent Development
11.13. Merck & Co., Inc.
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Benchmarking
11.13.4. Recent Development
11.14. Mylan N. V.
11.14.1. Company Overview
11.14.2. Financial Performance
11.14.3. Product Benchmarking
11.14.4. Recent Development
11.15. Novartis AG
11.15.1. Company Overview
11.15.2. Financial Performance
11.15.3. Product Benchmarking
11.15.4. Recent Development
11.16. Pfizer, Inc.
11.16.1. Company Overview
11.16.2. Financial Performance
11.16.3. Product Benchmarking
11.16.4. Recent Development
11.17. Sanofi
11.17.1. Company Overview
11.17.2. Financial Performance
11.17.3. Product Benchmarking
11.17.4. Recent Development
11.18. Sun Pharmaceutical Industries Ltd
11.18.1. Company Overview
11.18.2. Financial Performance
11.18.3. Product Benchmarking
11.18.4. Recent Development
11.19. Teva Pharmaceutical Industries Ltd.
11.19.1. Company Overview
11.19.2. Financial Performance
11.19.3. Product Benchmarking
11.19.4. Recent Development

List of Tables
Table 1. Global Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 2. Global Active Pharmaceutical Ingredient Market, by Form, by Region, 2016 - 2027 (USD Million)
Table 3. Global Active Pharmaceutical Ingredient Market, by Manufacturer, by Region, 2016 - 2027 (USD Million)
Table 4. Global Active Pharmaceutical Ingredient Market, by Application, by Region, 2016 - 2027 (USD Million)
Table 5. Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016 - 2027 (USD Million)
Table 6. North America: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 7. North America: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 8. North America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 9. North America: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 10. U.S.: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 11. U.S.: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 12. U.S.: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 13. U.S.: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 14. Canada: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 15. Canada: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 16. Canada: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 17. Canada: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 18. Europe: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 19. Europe: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 20. Europe: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 21. Europe: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 22. UK: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 23. UK: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 24. UK: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 25. UK: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 26. France: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 27. France: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 28. France: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 29. France: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 30. Germany: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 31. Germany: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 32. Germany: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 33. Germany: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 34. Italy: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 35. Italy: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 36. Italy: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 37. Italy: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 38. Netherlands: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 39. Netherlands: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 40. Netherlands: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 41. Netherlands: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 42. Austria: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 43. Austria: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 44. Austria: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 45. Austria: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 46. Asia Pacific: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 47. Asia Pacific: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 48. Asia Pacific: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 49. Asia Pacific: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 50. China: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 51. China: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 52. China: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 53. China: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 54. India: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 55. India: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 56. India: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 57. India: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 58. Japan: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 59. Japan: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 60. Japan: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 61. Japan: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 62. Malaysia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 63. Malaysia: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 64. Malaysia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 65. Malaysia: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 66. Indonesia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 67. Indonesia: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 68. Indonesia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 69. Indonesia: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 70. South Korea: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 71. South Korea: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 72. South Korea: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 73. South Korea: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 74. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 75. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 76. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 77. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 78. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 79. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 80. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 81. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 82. Israel: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 83. Israel: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 84. Israel: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 85. Israel: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 86. South Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 87. South Africa: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 88. South Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 89. South Africa: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 90. Latin America: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 91. Latin America: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 92. Latin America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 93. Latin America: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 94. Brazil: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 95. Brazil: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 96. Brazil: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 97. Brazil: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 98. Mexico: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 99. Mexico: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 100. Mexico: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 101. Mexico: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
Table 102. Argentina: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
Table 103. Argentina: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
Table 104. Argentina: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
Table 105. Argentina: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)

List of Figures
Figure 1. Market Highlights (2019, Revenue)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top Down & Bottom Up Approach
Figure 4. Market by Geography
Figure 6. Porter’s Five Forces
Figure 7. Market by Product Type
Figure 8. Global Active Pharmaceutical Ingredient Market, By Product Type, 2019 & 2027 (USD Million)
Figure 9. Market by Form
Figure 8. Global Active Pharmaceutical Ingredient Market, By Form, 2019 & 2027 (USD Million)
Figure 9. Market by Manufacturer
Figure 10. Global Active Pharmaceutical Ingredient Market, By Manufacturer, 2019 & 2027 (USD Million)
Figure 11. Market by Application
Figure 12. Global Active Pharmaceutical Ingredient Market, By Application, 2019 & 2027 (USD Million)
Figure 13. Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016- 2027 (USD Million)
Figure 14. Strategic Analysis - Active Pharmaceutical Ingredient Market
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Albemarle Corporation
  • AstraZeneca
  • Aurobindo Pharma
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • ELI Lilly
  • Company
  • F. Hoffmann-La Roche
  • GlaxoSmithKline PLC
  • Lonza Group
  • Merck & Co. Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown